Tisdag 6 Oktober | 00:26:42 Europe / Stockholm
Svenska | English
Est. tid*
2027-09-09 08:00 Bokslutskommuniké 2027
2027-02-03 18:50 Kvartalsrapport 2027-Q2
2026-10-09 N/A X-dag ordinarie utdelning CHEMM 0.00 DKK
2026-10-08 N/A Årsstämma
2026-09-10 - Bokslutskommuniké 2026
2026-02-04 - Kvartalsrapport 2026-Q2
2025-10-10 - X-dag ordinarie utdelning CHEMM 7.00 DKK
2025-10-09 - Årsstämma
2025-09-11 - Bokslutskommuniké 2025
2025-02-05 - Kvartalsrapport 2025-Q2
2024-10-11 - X-dag ordinarie utdelning CHEMM 4.00 DKK
2024-10-10 - Årsstämma
2024-09-11 - Bokslutskommuniké 2024
2024-02-05 - Kvartalsrapport 2024-Q2
2023-10-13 - X-dag ordinarie utdelning CHEMM 6.00 DKK
2023-10-12 - Årsstämma
2023-09-14 - Bokslutskommuniké 2023
2023-05-09 - 15-10 2023-Q3
2023-02-09 - Kvartalsrapport 2023-Q2
2022-10-14 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2022-10-13 - Årsstämma
2022-09-15 - Bokslutskommuniké 2022
2022-02-08 - Kvartalsrapport 2022-Q2
2021-10-15 - X-dag ordinarie utdelning CHEMM 4.00 DKK
2021-10-14 - Årsstämma
2021-09-16 - Bokslutskommuniké 2021
2021-02-05 - Kvartalsrapport 2021-Q2
2020-10-09 - X-dag ordinarie utdelning CHEMM 1.50 DKK
2020-10-08 - Årsstämma
2020-09-17 - Bokslutskommuniké 2020
2020-02-07 - Kvartalsrapport 2020-Q2
2020-01-14 - X-dag bonusutdelning CHEMM 13
2020-01-13 - Extra Bolagsstämma 2020
2019-10-11 - X-dag ordinarie utdelning CHEMM 7.50 DKK
2019-10-10 - Årsstämma
2019-09-17 - Bokslutskommuniké 2019
2019-02-08 - Kvartalsrapport 2019-Q2
2018-10-12 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2018-10-11 - Årsstämma
2018-09-18 - Bokslutskommuniké 2018
2018-02-09 - Kvartalsrapport 2018-Q2
2017-11-15 - Årsstämma
2017-10-13 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2017-10-12 - Årsstämma
2017-09-19 - Bokslutskommuniké 2017
2017-02-10 - Kvartalsrapport 2017-Q2
2016-10-14 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2016-10-13 - Årsstämma
2016-09-20 - Bokslutskommuniké 2016
2016-02-26 - Kvartalsrapport 2016-Q2
2015-10-09 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2015-10-08 - Årsstämma
2015-05-15 - Kvartalsrapport 2015-Q3
2014-10-10 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2014-10-09 - Årsstämma
2014-05-15 - Kvartalsrapport 2014-Q3
2013-11-15 - Kvartalsrapport 2014-Q1
2013-10-11 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2013-10-10 - Årsstämma
2013-07-25 - Extra Bolagsstämma 2013
2013-05-14 - Kvartalsrapport 2013-Q3
2012-11-14 - Kvartalsrapport 2013-Q1
2012-10-12 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2012-10-11 - Årsstämma
2012-05-11 - Kvartalsrapport 2012-Q3
2011-11-11 - Kvartalsrapport 2012-Q1
2011-10-14 - X-dag ordinarie utdelning CHEMM 0.00 DKK
2011-10-13 - Årsstämma
2011-05-13 - Kvartalsrapport 2011-Q3
2010-11-12 - Kvartalsrapport 2011-Q1
2010-10-06 - X-dag ordinarie utdelning CHEMM 0.00 DKK
LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
ChemoMetec är verksamt inom medicinteknik. Bolaget är specialiserat mot design, utveckling och produktion av patenterade instrument för cellräkning och cellanalys. Bolaget samarbetar och stadgar avtal med aktörer som forskningsinstitut, universitet, livsmedelsbolag, sjukhus och specialkliniker. Kunderna återfinns på en global marknad. Bolaget grundades ursprungligen 1997 och har sitt huvudkontor i Alleröd, Danmark.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Major shareholder announcement - BlackRock, Inc.

2026-10-05 21:52:36

ANNOUNCEMENT NO. 318
5 October 2026

Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec that, on 29 September 2026, BlackRock, Inc. increased its voting rights attached to shares in ChemoMetec to 15.08%, thereby exceeding the 15% threshold under section 38 of the Danish Capital Markets Act.

BlackRock, Inc.’s position at that time was as follows:

  • Voting rights attached to shares: 15.08%
  • Voting rights through financial instruments: 0.00%
  • The total of both: 15.08%

BlackRock, Inc. has previously notified the following:

28 August 2026

BlackRock Investment Management (UK) Limited, which is part of the BlackRock Group, exceeded the 10% threshold under section 38 of the Danish Capital Markets Act and the 10% threshold for its total position under section 40 of the Danish Capital Markets Act.

BlackRock, Inc.’s total position on the same date was as follows:

  • Voting rights attached to shares: 12.98%
  • Voting rights through financial instruments: 0.05%
  • The total of both: 13.03%

At the same time, BlackRock Investment Management (UK) Limited held a total position of 10.04%, comprising 10.04% in voting rights attached to shares and 0.00% through financial instruments.

29 April 2026

BlackRock Investment Management (UK) Limited, which is part of the BlackRock Group, fell below the 10% threshold under section 40 of the Danish Capital Markets Act.

BlackRock, Inc.’s total position on the same date was as follows:

  • Voting rights attached to shares: 12.77%
  • Voting rights through financial instruments: 0.15%
  • The total of both: 12.92%

At the same time, BlackRock Investment Management (UK) Limited held a total position of 9.94%, comprising 9.79% in voting rights attached to shares and 0.15% through financial instruments.

22 April 2026

BlackRock Investment Management (UK) Limited, which is part of the BlackRock Group, fell below the 10% threshold under section 38 of the Danish Capital Markets Act.

BlackRock, Inc.’s total position on the same date was as follows:

  • Voting rights attached to shares: 12.94%
  • Voting rights through financial instruments: 0.18%
  • The total of both: 13.12%

At the same time, BlackRock Investment Management (UK) Limited held a total position of 10.15%, comprising 9.99% in voting rights attached to shares and 0.16% through financial instruments.


Additional Information

Martin Helbo Behrens, CEO
Tel.: (+45) 81 10 06 80 

Phillip Massie Price, CFO
Tel.: (+45) 81 10 06 80 


About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.


Källa GlobeNewswire Nordic
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Företag
Pressmeddelanden